Concordance assessment between a multiplexed competitive Luminex immunoassay, a multiplexed IgG Luminex immunoassay, and a pseudovirion-based neutralization assay for detection of human papillomaviruse types 16 and 18-Reference-Cited by-同舟云学术

Concordance assessment between a multiplexed competitive Luminex immunoassay, a multiplexed IgG Luminex immunoassay, and a pseudovirion-based neutralization assay for detection of human papillomaviruse types 16 and 18

Published:2014-10 Issue:44 Volume:32 Page:5880-5887
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Brown Darron,Müller Martin,Sehr Peter,Pawlita Michael,Seitz Hanna,Rubio Ivonne,Antonello Joseph,Radley David,Roberts Christine,Saah Alfred

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference16 articles.

1. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans: Vol 100, A Review of Human Carcinogens. Part B: Biological Agents;International Agency for Research on Cancer 2013,2011

2. Humoral immune response recognizes a complex set of epitopes on human papillomavirus type 6 l1 capsomers;Orozco;J Virol,2005

3. Surface conformational and linear epitopes on HPV-16 and HPV-18 L1 virus-like particles as defined by monoclonal antibodies;Christensen;Virology,1996

4. Identification of human papillomavirus type 16 L1 surface loops required for neutralization by human sera;Carter;J Virol,2006

5. Optimization and validation of a multiplexed luminex assay to quantify antibodies to neutralizing epitopes on human papillomavirus 6, 11, 16 and 18;Dias;Clin Diagn Lab Immunol,2005

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Validation of a triple‐color pseudovirion‐based neutralization assay for immunogenicity assessment of a 14‐valent recombinant human papillomavirus vaccine;Journal of Medical Virology;2024-08

2. Validation of Luminex immunological and competitive Luminex immunological assays for clinical immunogenicity assessment of a 14‐valent recombinant human papillomavirus vaccine;Journal of Medical Virology;2023-08

3. Development and Validation of Two Optimized Multiplexed Serologic Assays for the 9-Valent Human Papillomavirus Vaccine Types;mSphere;2023-04-20

4. Human Papillomavirus Vaccines;Plotkin's Vaccines;2023

5. Immunogenicity and safety of quadrivalent and 9-valent human papillomavirus vaccines in Indian clinical trial participants;Human Vaccines & Immunotherapeutics;2022-08-23